Transcriptomics

Dataset Information

0

Combination treatment with BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma


ABSTRACT: Epigenetic changes play a key role in the pathogenesis of medulloblastoma (MB), the most common malignant pediatric brain tumor. Here we identify a synergic vulnerability of BMI1High;CHD7Low MB cells to a combination treatment with BMI1 and MAPK/ERK inhibitors and we elucidate the molecular mechanisms underpinning the CHD7-BMI1-MAPK regulatory axis which mediates the anti-tumor effect of these inhibitors in vitro and in vivo, in a pre-clinical mouse model. Enhanced ERK1 and ERK2 phosphorylation activity is found in BMI1High;CHD7Low G4 MB patients, raising the possibility that they could be amenable to a similar therapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE172363 | GEO | 2022/02/28

REPOSITORIES: GEO

Similar Datasets

2019-06-23 | GSE83696 | GEO
| PRJNA723029 | ENA
2021-09-09 | PXD022057 | Pride
2014-11-18 | E-GEOD-63413 | biostudies-arrayexpress
2018-03-29 | GSE97170 | GEO
2013-04-12 | GSE45999 | GEO
2013-04-12 | E-GEOD-45999 | biostudies-arrayexpress
2018-03-29 | GSE97169 | GEO
2014-11-18 | E-GEOD-63411 | biostudies-arrayexpress
2015-05-12 | GSE54262 | GEO